Skip to content
10-K

Annual Report

DRUGS MADE IN AMERICA ACQUISITION CORP. DMAA DMAAR DMAAU

0001213900-25-026240

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 33.52M sh
Shares Diluted FY 2024 · Dec 31, 2024 8.57M sh
Eps Diluted FY 2024 · Dec 31, 2024 −$0.03
Eps Basic FY 2024 · Dec 31, 2024 −$0.03